Anti-TNF-alpha loss of response is associated with a decreased percentage of FoxP3+ T cells and a variant NOD2 genotype in patients with Crohn’s disease

被引：0
作者：
Oriol Juanola
Alba Moratalla
Ana Gutiérrez
Laura Sempere
Pedro Zapater
Paula Giménez
Isabel Almenta
Gloria Peiró
José M. González-Navajas
José F. Such
Rubén Francés
机构：
[1] CIBERehd,Servicio de Medicina Digestiva
[2] Instituto de Salud Carlos III,Servicio de Farmacología Clínica
[3] Hospital General Universitario de Alicante,Servicio de Anatomía Patológica
[4] Hospital General Universitario de Alicante,Dpto. Medicina Clínica
[5] Hospital General Universitario de Alicante,Digestive Disease Institute
[6] Universidad Miguel Hernández,undefined
[7] Cleveland Clinic Abu Dhabi,undefined
来源：
Journal of Gastroenterology | 2015年 / 50卷
关键词：
Crohn’s disease; FoxP3+ regulatory T cells; Anti-TNF-alpha;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：758 / 768
页数：10
相关论文
共 7 条
  • [1] Anti-TNF-alpha loss of response is associated with a decreased percentage of FoxP3+T cells and a variant NOD2 genotype in patients with Crohn's disease
    Juanola, Oriol
    Moratalla, Alba
    Gutierrez, Ana
    Sempere, Laura
    Zapater, Pedro
    Gimenez, Paula
    Almenta, Isabel
    Peiro, Gloria
    Gonzalez-Navajas, Jose M.
    Such, Jose F.
    Frances, Ruben
    JOURNAL OF GASTROENTEROLOGY, 2015, 50 (07) : 758 - 768
  • [2] NOD2 AND ATG16 L1 ARE ASSOCIATED WITH ANTI-TNF TROUGH LEVELS IN A COHORT OF PATIENTS WITH CROHN'S DISEASE
    Almenara, S.
    Egoavil, C. M.
    Londono, A. C.
    Gutierrez, A.
    Sempere, L.
    Zapater, P.
    Cameo, J., I
    Gonzalez-Navajas, J.
    Frances, R.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 94 - 95
  • [3] Anti tumour necrosis-α therapy increases the number of FOXP3+ regulatory T cells in children affected by Crohn's disease
    Ricciardelli, Ida
    Lindley, Keith J.
    Londei, Marco
    Quaratino, Sonia
    IMMUNOLOGY, 2008, 125 (02) : 178 - 183
  • [4] T2 enhances in situ level of Foxp3+ regulatory cells and modulates inflammatory cytokines in Crohn's disease
    Li, Guanwei
    Ren, Jianan
    Wang, Gefei
    Gu, Guosheng
    Hu, Dong
    Ren, Huajian
    Hong, Zhiwu
    Wu, Xiuwen
    Liu, Song
    Li, Jieshou
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2014, 18 (02) : 244 - 248
  • [5] Azathioprine discontinuation earlier than 6 months in Crohn's disease patients started on anti-TNF therapy is associated with loss of response and the need for anti-TNF dose escalation
    Viazis, Nikos
    Koukouratos, Theodoros
    Anastasiou, Jiannis
    Giakoumis, Marios
    Triantos, Christos
    Tsolias, Chrisostomos
    Theocharis, Georgios
    Karamanolis, Dimitrios G.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 27 (04) : 436 - 441
  • [6] 3020insC insertion in NOD2/CARD15 gene, a prevalent variant associated with anti-Saccharomyces cerevisiae antibodies and ileal location of Crohn's disease in Tunisian population
    Marrakchi, R.
    Bougatef, K.
    Moussa, A.
    Ouerhani, S.
    Khodjet-el-Khil, H.
    Messai, Y.
    Mestiri, O.
    Najar, T.
    Benammar-Elgaaeid, A.
    INFLAMMATION RESEARCH, 2009, 58 (04) : 218 - 223
  • [7] 3020insC insertion in NOD2/CARD15 gene, a prevalent variant associated with anti-Saccharomyces cerevisiae antibodies and ileal location of Crohn’s disease in Tunisian population
    R. Marrakchi
    K. Bougatef
    A. Moussa
    S. Ouerhani
    H. Khodjet-el-Khil
    Y. Messai
    O. Mestiri
    T. Najar
    A. Benammar-Elgaaeid
    Inflammation Research, 2009, 58 : 218 - 223
1